Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) reached a new 52-week high during trading on Thursday. The stock traded as high as $103.27 and last traded at $102.77, with a volume of 6,160 shares traded. The stock had previously closed at $101.21.
Analyst Ratings Changes
Separately, Erste Group Bank raised Sandoz Group to a “strong-buy” rating in a report on Thursday, August 27th. Four investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Strong Buy”.
View Our Latest Research Report on SDZNY
Sandoz Group Trading Up 0.2%
About Sandoz Group
Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.
Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.
Featured Articles
- Five stocks we like better than Sandoz Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
